APA (7th ed.) Citation

Nakabori, T., Kunimasa, K., Kawabata, M., Higashi, S., Mukai, K., Kawamura, T., . . . Ohkawa, K. (2024). Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants. Cancer Medicine, 13(12), 1. https://doi.org/10.1002/cam4.7430

Chicago Style (17th ed.) Citation

Nakabori, Tasuku, et al. "Feasibility of Atezolizumab and Bevacizumab Combination Regimens in Patients with Hepatocellular Carcinoma and Lung Cancer Taking Direct Oral Anticoagulants." Cancer Medicine 13, no. 12 (2024): 1. https://doi.org/10.1002/cam4.7430.

MLA (9th ed.) Citation

Nakabori, Tasuku, et al. "Feasibility of Atezolizumab and Bevacizumab Combination Regimens in Patients with Hepatocellular Carcinoma and Lung Cancer Taking Direct Oral Anticoagulants." Cancer Medicine, vol. 13, no. 12, 2024, p. 1, https://doi.org/10.1002/cam4.7430.